Labeler
Fresenius Kabi USA, LLC NDC Codes
Fresenius Kabi USA, LLC lists 714 finished drug products in the FDA NDC Directory under NDC labeler codes 63323, 65219, 76045.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Tyenne, Rocuronium, Sodium chloride, Dextrose, Otulfi, ketamine hydrochloride, Sterile Water, Levetiracetam, Cyclophosphamide, Vitalipid N, Ustekinumab-Aauz, Sodium Bicarbonate, ephedrine sulfate, Bomyntra, Succinylcholine Chloride
- Active ingredients
- Tocilizumab, Ustekinumab, Rocuronium bromide, Sodium chloride, Dextrose monohydrate, Phytonadione, Ketamine hydrochloride, Water, Levetiracetam, Denosumab, Cyclophosphamide, Vitamin a palmitate
- NDC labeler codes
- 63323, 65219, 76045
- Strengths (from the 100 most recently listed products)
- Rocuronium bromide 10 mg/mL; Dextrose monohydrate 50 mg/mL; Tocilizumab 162 mg/.9mL; Water 1 mL/mL; Sodium chloride .9 g/100mL; Ustekinumab 45 mg/.5mL; Ustekinumab 90 mg/mL; Ephedrine sulfate 5 mg/mL; Denosumab 70 mg/mL; Succinylcholine chloride dihydrate 20 mg/mL; Diphenhydramine hydrochloride 50 mg/mL; Amiodarone hydrochloride 50 mg/mL; Epinephrine 1 mg/mL; Chlorpromazine hydrochloride 25 mg/mL; Acyclovir sodium 50 mg/mL; Lorazepam 2 mg/mL; Gadobutrol 604.72 mg/mL; Desmopressin acetate 4 ug/mL; Vitamin a palmitate 230 [iU]/mL; Ergocalciferol 40 [iU]/mL
- Dosage forms
- Injection, Solution, Injection, Injection, Solution, Concentrate, Kit, Injection, Powder, For solution, Emulsion, Injection, Emulsion, Injection, Powder, Lyophilized, For solution, Solution
- Routes
- Intravenous, Subcutaneous, Intramuscular, Irrigation, Oral, Epidural, Infiltration, Perineural, Intraocular
- Drug classes (FDA established)
- Osmotic Laxative, Interleukin-6 Receptor Antagonist, Interleukin-12 Antagonist, Interleukin-23 Antagonist, Potassium Salt, Nondepolarizing Neuromuscular Blocker, General Anesthetic, alpha-Adrenergic Agonist, beta-Adrenergic Agonist, Vitamin K, Warfarin Reversal Agent, RANK Ligand Inhibitor, Benzodiazepine, Provitamin D2 Compound, Vitamin A, Norepinephrine Releasing Agent, Depolarizing Neuromuscular Blocker, Histamine-1 Receptor Antagonist, Antiarrhythmic, Catecholamine, Phenothiazine, Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor, Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor, Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor, Opioid Antagonist, Gadolinium-based Contrast Agent, Factor VIII Activator, Vasopressin Analog, alpha-1 Adrenergic Agonist, Vitamin C, Paramagnetic Contrast Agent, Lipoglycopeptide Antibacterial, Heparin Reversal Agent, beta-Adrenergic Blocker, Amide Local Anesthetic, Calcitonin, Antifibrinolytic Agent, Calcium Channel Blocker, Dihydropyridine Calcium Channel Blocker, Proton Pump Inhibitor, Oxytocic, Corticosteroid, Anticholinergic
- HCPCS / J-code
- J3357 — Injection, ustekinumab, for subcutaneous injection, 1 mg, J0897 — Injection, denosumab, 1 mg, J0171 — Injection, adrenalin, epinephrine, 0.1 mg
- Package NDCs
- 108 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Aztreonam | Aztreonam 2 g/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | 63323-402 | 63323-0402-24 | — |
| Aztreonam | Aztreonam 2 g/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | 63323-402 | 63323-0402-20 | — |
| Chlorothiazidechlorothiazide sodium | Chlorothiazide sodium 500 mg/18mL | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-658 | 63323-0658-27 | — |
| Chlorothiazidechlorothiazide sodium | Chlorothiazide sodium 500 mg/18mL | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-658 | 63323-0658-20 | — |
| Chlorothiazidechlorothiazide sodium | Chlorothiazide sodium 500 mg/18mL | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-658 | 63323-0658-94 | — |
| Piperacillin and Tazobactampiperacillin sodium,tazobactam sodium | Piperacillin sodium 3 g/15mL; Tazobactam sodium .375 g/15mL | Injection, Powder, For solutionIntravenous | 63323-300 | 63323-0300-30 | — |
| Piperacillin and Tazobactampiperacillin sodium,tazobactam sodium | Piperacillin sodium 3 g/15mL; Tazobactam sodium .375 g/15mL | Injection, Powder, For solutionIntravenous | 63323-300 | 63323-0300-36 | — |
| Piperacillin and Tazobactampiperacillin sodium,tazobactam sodium | Piperacillin sodium 2 g/10mL; Tazobactam sodium .25 g/10mL | Injection, Powder, For solutionIntravenous | 63323-309 | 63323-0309-20 | — |
| Piperacillin and Tazobactampiperacillin sodium,tazobactam sodium | Piperacillin sodium 2 g/10mL; Tazobactam sodium .25 g/10mL | Injection, Powder, For solutionIntravenous | 63323-309 | 63323-0309-26 | — |
| Piperacillin and Tazobactampiperacillin sodium,tazobactam sodium | Piperacillin sodium 4 g/20mL; Tazobactam sodium .5 g/20mL | Injection, Powder, For solutionIntravenous | 63323-320 | 63323-0320-50 | — |
| Piperacillin and Tazobactampiperacillin sodium,tazobactam sodium | Piperacillin sodium 4 g/20mL; Tazobactam sodium .5 g/20mL | Injection, Powder, For solutionIntravenous | 63323-320 | 63323-0320-56 | — |
| Naropinropivacaine hydrochloride | Ropivacaine hydrochloride 2 mg/mL | Injection, SolutionEpidural, Infiltration | 63323-285 | 63323-0285-2863323-0285-6863323-0285-73 | — |
| Naropinropivacaine hydrochloride | Ropivacaine hydrochloride 2 mg/mL | Injection, SolutionEpidural, Infiltration | 63323-285 | 63323-0285-67 | — |
| Naropinropivacaine hydrochloride | Ropivacaine hydrochloride 5 mg/mL | Injection, SolutionEpidural, Infiltration, Perineural | 63323-286 | 63323-0286-2763323-0286-38 | — |
| Naropinropivacaine hydrochloride | Ropivacaine hydrochloride 5 mg/mL | Injection, SolutionEpidural, Infiltration, Perineural | 63323-286 | 63323-0286-95 | — |
| Naropinropivacaine hydrochloride | Ropivacaine hydrochloride 10 mg/mL | Injection, SolutionEpidural | 63323-288 | 63323-0288-29 | — |
| Polocaine-MPFmepivacaine hydrochloride | Mepivacaine hydrochloride 15 mg/mL | Injection, SolutionEpidural, Infiltration | 63323-293 | 63323-0293-37 | — |
| Polocaine-MPFmepivacaine hydrochloride | Mepivacaine hydrochloride 20 mg/mL | Injection, SolutionEpidural, Infiltration | 63323-294 | 63323-0294-27 | — |
| Polocainemepivacaine hydrochloride | Mepivacaine hydrochloride 10 mg/mL | Injection, SolutionInfiltration | 63323-283 | 63323-0283-57 | — |
| Polocainemepivacaine hydrochloride | Mepivacaine hydrochloride 20 mg/mL | Injection, SolutionInfiltration | 63323-296 | 63323-0296-57 | — |
| Polocaine-MPFmepivacaine hydrochloride | Mepivacaine hydrochloride 10 mg/mL | Injection, SolutionEpidural, Infiltration | 63323-260 | 63323-0260-37 | — |
| Irinotecan Hydrochloride | Irinotecan hydrochloride 20 mg/mL | Injection, SolutionIntravenous | 63323-193 | 63323-0193-5263323-0193-55 | — |
| Paclitaxel | Paclitaxel 6 mg/mL | Injection, SolutionIntravenous | 63323-763 | 63323-0763-1663323-0763-50 | — |
| Bleomycinbleomycin sulfate | Bleomycin sulfate 15 [USP'U]/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intrapleural, Intravenous, Subcutaneous | 63323-136 | 63323-0136-10 | — |
| Bleomycinbleomycin sulfate | Bleomycin sulfate 30 [USP'U]/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intrapleural, Intravenous, Subcutaneous | 63323-137 | 63323-0137-20 | — |
| Fludarabinefludarabine phosphate | Fludarabine phosphate 25 mg/mL | Injection, SolutionIntravenous | 63323-192 | 63323-0192-02 | — |
| Mitoxantronemitoxantrone hydrochloride | Mitoxantrone hydrochloride 2 mg/mL | Injection, SolutionIntravenous | 63323-132 | 63323-0132-1063323-0132-1263323-0132-15 | — |
| Azithromycinazithromycin monohydrate | Azithromycin monohydrate 500 mg/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-398 | 63323-0398-10 | — |
| Azithromycinazithromycin monohydrate | Azithromycin monohydrate 500 mg/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-398 | 63323-0398-14 | — |
| Octreotideoctreotide acetate | Octreotide acetate 100 ug/mL | Injection, SolutionIntravenous, Subcutaneous | 63323-376 | 63323-0376-01 | — |
| Octreotideoctreotide acetate | Octreotide acetate 100 ug/mL | Injection, SolutionIntravenous, Subcutaneous | 63323-376 | 63323-0376-04 | — |
| Octreotideoctreotide acetate | Octreotide acetate 500 ug/mL | Injection, SolutionIntravenous, Subcutaneous | 63323-377 | 63323-0377-01 | — |
| Octreotideoctreotide acetate | Octreotide acetate 500 ug/mL | Injection, SolutionIntravenous, Subcutaneous | 63323-377 | 63323-0377-04 | — |
| Octreotideoctreotide acetate | Octreotide acetate 200 ug/mL | Injection, SolutionIntravenous, Subcutaneous | 63323-378 | 63323-0378-05 | — |
| Octreotideoctreotide acetate | Octreotide acetate 1000 ug/mL | Injection, SolutionIntravenous, Subcutaneous | 63323-379 | 63323-0379-05 | — |
| Adenosine | Adenosine 3 mg/mL | Injection, SolutionIntravenous | 63323-651 | 63323-0651-0263323-0651-04 | — |
| Tobramycintobramycin sulfate | Tobramycin sulfate 1200 mg/30mL | Injection, Powder, For solutionIntravenous | 63323-303 | 63323-0303-55 | — |
| Tobramycintobramycin sulfate | Tobramycin sulfate 1200 mg/30mL | Injection, Powder, For solutionIntravenous | 63323-303 | 63323-0303-51 | — |
| Tobramycintobramycin sulfate | Tobramycin sulfate 40 mg/mL | Injection, SolutionIntramuscular, Intravenous | 63323-306 | 63323-0306-0263323-0306-30 | — |
| Dexamethasone Sodium Phosphate | Dexamethasone sodium phosphate 10 mg/mL | Injection, SolutionIntramuscular, Intravenous | 63323-516 | 63323-0516-10 | — |
| Flumazenil | Flumazenil .1 mg/mL | Injection, SolutionIntravenous | 63323-424 | 63323-0424-0563323-0424-10 | — |
| Cladribine | Cladribine 1 mg/mL | InjectionIntravenous | 63323-140 | 63323-0140-10 | — |
| Methylprednisolone Sodium Succinate | Methylprednisolone sodium succinate 1 g/16mL | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | 63323-265 | 63323-0265-30 | — |
| Esmolol Hydrochloride | Esmolol hydrochloride 10 mg/mL | Injection, SolutionIntravenous | 63323-652 | 63323-0652-10 | — |
| Tobramycintobramycin sulfate | Tobramycin sulfate 10 mg/mL | Injection, SolutionIntramuscular, Intravenous | 63323-305 | 63323-0305-02 | — |
| Vancomycin Hydrochloride | Vancomycin hydrochloride 10 g/100mL | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-314 | 63323-0314-66 | — |
| Esmolol Hydrochloride | Esmolol hydrochloride 10 mg/mL | Injection, SolutionIntravenous | 63323-661 | 63323-0661-14 | — |
| Vancomycin Hydrochloride | Vancomycin hydrochloride 10 g/100mL | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-314 | 63323-0314-61 | — |
| Methylprednisolone Sodium Succinate | Methylprednisolone sodium succinate 40 mg/mL | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | 63323-255 | 63323-0255-03 | — |
| Methylprednisolone Sodium Succinate | Methylprednisolone sodium succinate 125 mg/2mL | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | 63323-258 | 63323-0258-03 | — |
Fresenius Kabi USA, LLC: common questions
- What is Fresenius Kabi USA, LLC's NDC labeler code?
- 63323, 65219, 76045. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Fresenius Kabi USA, LLC?
- Med-Code's HCPCS directory matches J3357, J0897, J0171 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.